Extracellular signal-regulated kinase-2 within the ventral tegmental area regulates responses to stress

Journal of Neuroscience

Volumn 30, Issue 22, 2010, Pages 7652-7663

  Iñiguez, Sergio D ^a   Vialou, Vincent ^b   Warren, Brandon L ^a   Cao, Jun Li ^b   Alcantara, Lyonna F ^a   Davis, Lindsey C ^a   Manojlovic, Zarko ^a   Neve, Rachael L ^c   Russo, Scott J ^b   Han, Ming Hu ^b   Nestler, Eric J ^b   Bolaños Guzmán, Carlos A ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; S6 KINASE; SUCROSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; C57BL 6 MOUSE; CHRONIC STRESS; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; ENZYME SUBSTRATE; FORCED SWIMMING TEST; GENE TRANSFER; HERPES SIMPLEX VIRUS; MALE; MAZE TEST; MOOD; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOCIAL STRESS; SPRAGUE DAWLEY RAT; STRESS; VENTRAL TEGMENTUM;

ACTION POTENTIALS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; DOMINANCE-SUBORDINATION; ELECTROSHOCK; ESCAPE REACTION; FOOD PREFERENCES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GREEN FLUORESCENT PROTEINS; HINDLIMB SUSPENSION; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOTOR ACTIVITY; NEURONS; ONCOGENE PROTEINS, FUSION; PAIN; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; SIMPLEXVIRUS; STRESS, PSYCHOLOGICAL; SUCROSE; SWEETENING AGENTS; SWIMMING; TIME FACTORS; TRANSDUCTION, GENETIC; TYROSINE 3-MONOOXYGENASE; VENTRAL TEGMENTAL AREA;

EID: 77953189643     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.0951-10.2010     Document Type: Article

References (117)

1. Alonso M, Vianna MR, Izquierdo I, Medina JH (2002) Signaling mechanisms mediating BDNF modulation of memory formation in vivo in the hippocampus. Cell Mol Neurobiol 22:663-674. (Pubitemid 36169215)
2. Anisman H, Zacharko RM (1986) Behavioral and neurochemical consequences associated with stressors. Ann NY Acad Sci 467:205-225. (Pubitemid 16029627)
3. Anstrom KK, Woodward DJ (2005) Restraint increases dopaminergic burst firing in awake rats. Neuropsychopharmacology 30:1832-1840.
4. Aouadi M, Binetruy B, Caron L, Le Marchand-Brustel Y, Bost F (2006) Role of MAPKs in development and differentiation: lessons from knockout mice. Biochimie 88:1091-1098.
5. Barrot M, Olivier JD, Perrotti LI, DiLeone RJ, Berton O, Eisch AJ, Impey S, Storm DR, Neve RL, Yin JC, Zachariou V, Nestler EJ (2002) CREB activity in the nucleus accumbens shell controls gating of behavioral responses to emotional stimuli. Proc Natl Acad Sci U S A 99:11435-11440. (Pubitemid 34920943)
6. Bell-Horner CL, Dohi A, Nguyen Q, Dillon GH, Singh M (2006) ERK/ MAPK pathway regulates GABAA receptors. J Neurobiol 66:1467-1474. (Pubitemid 44715754)
7. Berhow MT, Hiroi N, Nestler EJ (1996) Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707-4715. (Pubitemid 26251066)
8. Bertolucci-D'Angio M, Serrano A, Driscoll P, Scatton B (1990) Involvement of mesocorticolimbic dopaminergic systems in emotional states. Prog Brain Res 85:405- 416; discussion 416-417.
9. Berton O, McClung CA, Dileone RJ, Krishnan V, Renthal W, Russo SJ, Graham D, Tsankova NM, Bolanos CA, Rios M, Monteggia LM, Self DW, Nestler EJ (2006) Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science 311:864-868. (Pubitemid 43228853)
10. Bolaños CA, Nestler EJ (2004) Neurotrophic mechanisms in drug addiction. Neuromolecular Med 5:69-83.
11. Bolaños CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003a) Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54:1317-1329.
12. Bolaños CA, Perrotti LI, Edwards S, Eisch AJ, Barrot M, Olson VG, Russell DS, Neve RL, Nestler EJ (2003b) Phospholipase Cγ in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J Neurosci 23:7569-7576. (Pubitemid 37034073)
13. Bonnet KA, Peterson KE (1975) A modification of the jump-flinch technique for measuring pain sensitivity in rats. Pharmacol Biochem Behav 3:47-55.
14. Carlezon WA Jr, Boundy VA, Haile CN, Lane SB, Kalb RG, Neve RL, Nestler EJ (1997) Sensitization to morphine induced by viral-mediated gene transfer. Science 277:812-814.
15. Carlezon WA Jr, Thome J, Olson VG, Lane-Ladd SB, Brodkin ES, Hiroi N, Duman RS, Neve RL, Nestler EJ (1998) Regulation of cocaine reward by CREB. Science 282:2272-2275.
16. Conner JM, Lauterborn JC, Yan Q, Gall CM, Varon S (1997) Distribution of brain-derived neurotrophic factor (BDNF) protein and mRNA in the normal adult rat CNS: evidence for anterograde axonal transport. J Neurosci 17:2295-2313. (Pubitemid 27137397)
17. Council NR (2003) Guideliness for the care and use of mammals in neuroscience and behavioral research. Washington, DC: National Academy.
18. Covington HE 3rd, Miczek KA (2005) Intense cocaine self-administration after episodic social defeat stress, but not after aggressive behavior: dissociation from corticosterone activation. Psychopharmacology (Berl) 183:331-340.
19. Creson TK, Hao Y, Engel S, Shen Y, Hamidi A, Zhuo M, Manji HK, Chen G (2009) The anterior cingulate ERK pathway contributes to regulation of behavioral excitement and hedonic activity. Bipolar Disord 11:339-350.
20. Cryan JF, Markou A, Lucki I (2002) Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol Sci 23:238-245. (Pubitemid 34465544)
21. Cryan JF, Mombereau C, Vassout A (2005) The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29:571-625. (Pubitemid 40755457)
22. Detke MJ, Lucki I (1996) Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behav Brain Res 73:43-46.
23. Di Chiara G, Loddo P, Tanda G (1999) Reciprocal changes in prefrontal and limbic dopamine responsiveness to aversive and rewarding stimuli after chronic mild stress: implications for the psychobiology of depression. Biol Psychiatry 46:1624-1633. (Pubitemid 30001604)
24. Duman CH, Schlesinger L, Kodama M, Russell DS, Duman RS (2007) Arole for MAP kinase signaling in behavioral models of depression and antidepressant treatment. Biol Psychiatry 61:661-670. (Pubitemid 46328865)
25. Duman RS, Monteggia LM (2006) A neurotrophic model for stress-related mood disorders. Biol Psychiatry 59:1116-1127. (Pubitemid 43912554)
26. Dwivedi Y, Rizavi HS, Conley RR, Pandey GN (2006) ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 11:86-98. (Pubitemid 43251091)
27. Einat H, Yuan P, Gould TD, Li J, Du J, Zhang L, Manji HK, Chen G (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 23:7311-7316. (Pubitemid 36999520)
28. Eisch AJ, Bolaños CA, de Wit J, Simonak RD, Pudiak CM, Barrot M, Verhaagen J, Nestler EJ (2003) Brain-derived neurotrophic factor in the ventral midbrain-nucleus accumbens pathway: a role in depression. Biol Psychiatry 54:994-1005. (Pubitemid 37415034)
29. Ferguson SM, Fasano S, Yang P, Brambilla R, Robinson TE (2006) Knockout of ERK1 enhances cocaine-evoked immediate early gene expression and behavioral plasticity. Neuropsychopharmacology 31:2660-2668. (Pubitemid 44764163)
30. Fibiger HC, Phillips AG (1981) Increased intracranial self-stimulation in rats after long-term administration of desipramine. Science 214:683-685.
31. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ (1996) Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16:274-282.
32. Fumagalli F, Molteni R, Calabrese F, Frasca A, Racagni G, Riva MA (2005) Chronic fluoxetine administration inhibits extracellular signal-regulated kinase 1/2 phosphorylation in rat brain. J Neurochem 93:1551-1560.
33. Girault JA, Valjent E, Caboche J, Hervé D (2007) ERK2: a logical AND gate critical for drug-induced plasticity? Curr Opin Pharmacol 7:77-85.
34. Gourley SL, Wu FJ, Kiraly DD, Ploski JE, Kedves AT, Duman RS, Taylor JR (2008) Regionally specific regulation of ERK MAP kinase in a model of antidepressant-sensitive chronic depression. Biol Psychiatry 63:353-359.
35. Graham DL, Krishnan V, Larson EB, Graham A, Edwards S, Bachtell RK, Simmons D, Gent LM, Berton O, Bolanos CA, DiLeone RJ, Parada LF, Nestler EJ, Self DW (2009) Tropomyosin-related kinase B in the mesolimbic dopamine system: region-specific effects on cocaine reward. Biol Psychiatry 65:696-701.
36. Guarraci FA, Kapp BS (1999) An electrophysiological characterization of ventral tegmental area dopaminergic neurons during differential pavlovian fear conditioning in the awake rabbit. Behav Brain Res 99:169-179.
37. Han MH, Bolaños CA, Green TA, Olson VG, Neve RL, Liu RJ, Aghajanian GK, Nestler EJ (2006) Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors. J Neurosci 26:4624-4629.
38. Hetman M, Gozdz A (2004) Role of extracellular signal regulated kinases 1 and 2 in neuronal survival. Eur J Biochem 271:2050-2055. (Pubitemid 38747973)
39. Horger BA, Roth RH (1996) The role of mesoprefrontal dopamine neurons in stress. Crit Rev Neurobiol 10:395-418.
40. Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR (1999) Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J Neurosci 19:4110-4122.
41. Huang EJ, Reichardt LF (2003) Trk receptors: roles in neuronal signal transduction. Annu Rev Biochem 72:609-642.
42. Huang TY, Lin CH (2006) Role of amygdala MAPK activation on immobility behavior of forced swim rats. Behav Brain Res 173:104-111.
43. Iñiguez SD, Warren BL, Neve RL, Nestler EJ, Russo SJ, Bolaños-Guzmán CA (2008) Insulin receptor substrate-2 in the ventral tegmental area regulates behavioral responses to cocaine. Behav Neurosci 122:1172-1177.
44. Iñiguez SD, Warren BL, Parise EM, Alcantara LF, Schuh B, Maffeo ML, Manojlovic Z, Bolaños-Guzmán CA (2009) Nicotine exposure during adolescence induces a depression-like state in adulthood. Neuropsychopharmacology 34:1609-1624.
45. Iñiguez SD, Warren BL, Bolaños-Guzmán CA (2010) Short- and long-term functional consequences of fluoxetine exposure during adolescence in male rats. Biol Psychiatry 67:1057-1066.
46. Jensen J, McIntosh AR, Crawley AP, Mikulis DJ, Remington G, Kapur S (2003) Direct activation of the ventral striatum in anticipation of aversive stimuli. Neuron 40:1251-1257.
47. Kelley AE, Berridge KC (2002) The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci 22:3306-3311.
48. Koob GF (1996) Hedonic valence, dopamine and motivation. Mol Psychiatry 1:186-189.
49. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129.
50. Kosten TR, Markou A, Koob GF (1998) Depression and stimulant dependence: neurobiology and pharmacotherapy. J Nerv Ment Dis 186:737-745.
51. Kreibich AS, Briand L, Cleck JN, Ecke L, Rice KC, Blendy JA (2009) Stress-induced potentiation of cocaine reward: a role for CRF R1 and CREB. Neuropsychopharmacology 34:2609-2617.
52. Krishnan V, Nestler EJ (2008) The molecular neurobiology of depression. Nature 455:894-902.
53. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, Russo SJ, Laplant Q, Graham A, Lutter M, Lagace DC, Ghose S, Reister R, Tannous P, Green TA, Neve RL, Chakravarty S, Kumar A, Eisch AJ, Self DW, Lee FS, Tamminga CA, Cooper DC, Gershenfeld HK, Nestler EJ (2007) Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 131:391-404.
54. Krishnan V, Han MH, Mazei-Robison M, Iñiguez SD, Ables JL, Vialou V, Berton O, Ghose S, Covington HE 3rd, Wiley MD, Henderson RP, Neve RL, Eisch AJ, Tamminga CA, Russo SJ, Bolaños CA, Nestler EJ (2008) AKT signaling within the ventral tegmental area regulates cellular and behavioral responses to stressful stimuli. Biol Psychiatry 64:691-700.
55. Lin X, Wang Q, Ji J, Yu LC (2010) Role of MEK-ERK pathway in morphine-induced conditioned place preference in ventral tegmental area of rats. J Neurosci Res 88:1595-1604.
56. Lloyd AC (2006) Distinct functions for ERKs? J Biol 5:13.
57. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24:1604-1611.
58. Lu L, Koya E, Zhai H, Hope BT, Shaham Y (2006) Role of ERK in cocaine addiction. Trends Neurosci 29:695-703.
59. Lu L, Wang X, Wu P, Xu C, Zhao M, Morales M, Harvey BK, Hoffer BJ, Shaham Y (2009) Role of ventral tegmental area glial cell line-derived neurotrophic factor in incubation of cocaine craving. Biol Psychiatry 66:137-145.
60. Lucki I (1997) The forced swimming test as a model for core and component behavioral effects of antidepressant drugs. Behav Pharmacol 8:523-532.
61. Manji HK, Chen G (2002) PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry 7 [Suppl 1]:S46-S56.
62. Manji HK, Moore GJ, Chen G (2000) Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48:740-754.
63. Montgomery KC (1955) The relation between fear induced by novel stimulation and exploratory behavior. J Comp Physiol Psychol 48:254-260.
64. Naranjo CA, Tremblay LK, Busto UE (2001) The role of the brain reward system in depression. Prog Neuropsychopharmacol Biol Psychiatry 25:781-823.
65. Nestler EJ, Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59:1151-1159.
66. Nestler EJ, Berhow MT, Brodkin ES (1996) Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. Mol Psychiatry 1:190-199.
67. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM (2002) Neurobiology of depression. Neuron 34:13-25.
68. Neve RL, Howe JR, Hong S, Kalb RG (1997) Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus. Neuroscience 79:435-447.
69. Nishimoto S, Nishida E (2006) MAPK signalling: ERK5 versus ERK1/2. EMBO Rep 7:782-786.
70. Numan S, Seroogy KB (1999) Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study. J Comp Neurol 403:295-308.
71. Olson VG, Zabetian CP, Bolanos CA, Edwards S, Barrot M, Eisch AJ, Hughes T, Self DW, Neve RL, Nestler EJ (2005) Regulation of drug reward by cAMP response element-binding protein: evidence for two functionally distinct subregions of the ventral tegmental area. J Neurosci 25:5553-5562.
72. Ortiz J, Harris HW, Guitart X, Terwilliger RZ, Haycock JW, Nestler EJ (1995) Extracellular signal-regulated protein kinases (ERKs) and ERK kinase (MEK) in brain: regional distribution and regulation by chronic morphine. J Neurosci 15:1285-1297.
73. Ortiz J, Fitzgerald LW, Lane S, Terwilliger R, Nestler EJ (1996) Biochemical adaptations in the mesolimbic dopamine system in response to repeated stress. Neuropharmacology 14:443-452.
74. Papp M, Willner P, Muscat R (1991) An animal model of anhedonia: attenuation of sucrose consumption and place preference conditioning by chronic unpredictable mild stress. Psychopharmacology (Berl) 104:255-259.
75. Paxinos G, Watson C (1997) The rat brain in stereotaxic coordinates, Ed 3. San Diego: Academic.
76. Perrotti LI, Hadeishi Y, Ulery PG, Barrot M, Monteggia L, Duman RS, Nestler EJ (2004) Induction of delta FosB in reward-related brain structures after chronic stress. J Neurosci 24:10594-10602.
77. Pierce RC, Bari AA (2001) The role of neurotrophic factors in psychostimulant-induced behavioral and neuronal plasticity. Rev Neurosci 12:95-110.
78. Pliakas AM, Carlson RR, Neve RL, Konradi C, Nestler EJ, Carlezon WA Jr (2001) Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci 21:7397-7403.
79. Poo MM (2001) Neurotrophins as synaptic modulators. Nat Rev Neurosci 2:24-32.
80. Porsolt RD, Le Pichon M, Jalfre M (1977) Depression: a new animal model sensitive to antidepressant treatments. Nature 266:730-732.
81. Porsolt RD, Chermat R, Lenègre A, Avril I, Janvier S, Stéru L (1987) Use of the automated tail suspension test for the primary screening of psychotropic agents. Arch Int Pharmacodyn Ther 288:11-30. (Pubitemid 17134783)
82. Posternak MA (2003) Biological markers of atypical depression. Harv Rev Psychiatry 11:1-7.
83. Pucilowski O, Overstreet DH, Rezvani AH, Janowsky DS (1993) Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol Behav 54:1215-1220.
84. Qi X, Lin W, Wang D, Pan Y, Wang W, Sun M (2009) A role for the extracellular signal-regulated kinase signal pathway in depressive-like behavior. Behav Brain Res 199:203-209.
85. Rattiner LM, Davis M, Ressler KJ (2005) Brain-derived neurotrophic factor in amygdala-dependent learning. Neuroscientist 11:323-333. (Pubitemid 41040861)
86. Robinson MJ, Harkins PC, Zhang J, Baer R, Haycock JW, Cobb MH, Goldsmith EJ (1996) Mutation of position 52 in ERK2 creates a nonproductive binding mode for adenosine 5′-triphosphate. Biochemistry 35:5641-5646. (Pubitemid 26143659)
87. Russo SJ, Bolanos CA, Theobald DE, DeCarolis NA, Renthal W, Kumar A, Winstanley CA, Renthal NE, Wiley MD, Self DW, Russell DS, Neve RL, Eisch AJ, Nestler EJ (2007) IRS2-Akt pathway in midbrain dopamine neurons regulates behavioral and cellular responses to opiates. Nat Neurosci 10:93-99. (Pubitemid 46026532)
88. Russo-Neustadt AA, Beard RC, Huang YM, Cotman CW (2000) Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus. Neuroscience 101:305-312.
89. Saal D, Dong Y, Bonci A, Malenka RC (2003) Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 37:577-582. (Pubitemid 36262980)
90. Sampson D, Muscat R, Phillips G, Willner P (1992) Decreased reactivity to sweetness following chronic exposure to mild unpredictable stress or acute administration of pimozide. Neurosci Biobehav Rev 16:519-524.
91. Schmidt HD, Duman RS (2007) The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behav Pharmacol 18:391-418.
92. Schoenbaum G, Stalnaker TA, Shaham Y (2007) A role for BDNF in cocaine reward and relapse. Nat Neurosci 10:935-936. (Pubitemid 47185191)
93. Schuman EM (1999) Neurotrophin regulation of synaptic transmission. Curr Opin Neurobiol 9:105-109.
94. Selcher JC, Nekrasova T, Paylor R, Landreth GE, Sweatt JD (2001) Mice lacking the ERK1 isoform of MAP kinase are unimpaired in emotional learning. Learn Mem 8:11-19.
95. Shaham Y, Erb S, Stewart J (2000) Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev 33:13-33.
96. Shirayama Y, Chen AC, Nakagawa S, Russell DS, Duman RS (2002) Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J Neurosci 22:3251-3261. (Pubitemid 35379212)
97. Spruijt BM, Welbergen P, Brakkee J, Gispen WH (1988) An ethological analysis of excessive grooming in young and aged rats. Ann NY Acad Sci 525:89-100.
98. Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367-370. (Pubitemid 15123115)
99. Subramaniam S, Unsicker K (2010) ERK and cell death: ERK1/2 in neuronal death. FEBS J 277:22-29.
100. Tacchi R, Ferrari A, Loche A, Bertolini A (2008) Sucrose intake: increase in non-stressed rats and reduction in chronically stressed rats are both prevented by the gamma-hydroxybutyrate (GHB) analogue, GET73. Pharmacol Res 57:464-468.
101. Todorovic C, Sherrin T, Pitts M, Hippel C, Rayner M, Spiess J (2009) Suppression of the MEK/ERK signaling pathway reverses depression-like behaviors of CRF2-deficient mice. Neuropsychopharmacology 34:1416-1426.
102. Tronson NC, Schrick C, Fischer A, Sananbenesi F, Pagès G, Pouysségur J, Radulovic J (2008) Regulatory mechanisms of fear extinction and depression-like behavior. Neuropsychopharmacology 33:1570-1583. (Pubitemid 351684712)
103. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525.
104. Ungless MA, Magill PJ, Bolam JP (2004) Uniform inhibition of dopamine neurons in the ventral tegmental area by aversive stimuli. Science 303:2040-2042. (Pubitemid 38393283)
105. Werkman TR, Olijslagers JE, Perlstein B, Jansen AH, McCreary AC, Kruse CG, Wadman WJ (2004) Quetiapine increases the firing rate of rat substantia nigra and ventral tegmental area dopamine neurons in vitro. Eur J Pharmacol 506:47-53. (Pubitemid 39575084)
106. Wiley MD, Poveromo LB, Antapasis J, Herrera CM, Bolaños Guzmán CA (2009) Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate. Neuropsychopharmacology 34:1339-1350.
107. Willner P (1983) Dopamine and depression: a review of recent evidence. I. Empirical studies. Brain Res 287:211-224.
108. Willner P, Towell A, Sampson D, Sophokleous S, Muscat R (1987) Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant. Psychopharmacology (Berl) 93:358-364. (Pubitemid 17160661)
109. Willner P, Benton D, Brown E, Cheeta S, Davies G, Morgan J, Morgan M (1998) "Depression" increases "craving" for sweet rewards in animal and human models of depression and craving. Psychopharmacology (Berl) 136:272-283.
110. Wise RA (1987) The role of reward pathways in the development of drug dependence. Pharmacol Ther 35:227-263.
111. Wise RA (2004) Dopamine, learning and motivation. Nat Rev Neurosci 5:483-494.
112. Wise RA, Bozarth MA (1987) Apsychomotor stimulant theory of addiction. Psychol Rev 94:469-492.
113. Yadid G, Friedman A (2008) Dynamics of the dopaminergic system as a key component to the understanding of depression. Prog Brain Res 172:265-286.
114. Yan Q, Radeke MJ, Matheson CR, Talvenheimo J, Welcher AA, Feinstein SC (1997) Immunocytochemical localization of TrkB in the central nervous system of the adult rat. J Comp Neurol 378:135-157. (Pubitemid 27057536)
115. Yap JJ, Miczek KA (2008) Stress and rodent models of drug addiction: role of VTA-accumbens-PFC-amygdala circuit. Drug Discov Today Dis Models 5:259-270.
116. Yoon S, Seger R (2006) The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24:21-44. (Pubitemid 43108774)
117. Zacharko RM, Bowers WJ, Kokkinidis L, Anisman H (1983) Region-specific reductions of intracranial self-stimulation after uncontrollable stress: possible effects on reward processes. Behav Brain Res 9:129-141. (Pubitemid 13075066)